Tackling inflammation in atherosclerosis: Are we there yet and what lies beyond?

Area of Science:

• Cardiovascular Medicine
• Inflammation Research
• Translational Therapeutics

Background:

• Atherosclerosis is a chronic, non-resolving inflammatory disease of the arteries.
• It remains a leading global cause of death and disability, despite effective lipid-lowering treatments.
• Recent trials indicate that reducing inflammation can prevent adverse cardiovascular outcomes.

Purpose of the Study:

• To review key anti-inflammatory and pro-resolution pathways relevant to atherosclerosis.
• To discuss the potential of targeting these pathways to modify disease progression.
• To identify challenges in translating inflammation-targeting therapies into clinical practice for atherosclerotic heart disease.

Main Methods:

• Literature review of anti-inflammatory and pro-resolution mechanisms in atherosclerosis.
• Analysis of recent clinical trial data supporting inflammation suppression.
• Discussion of therapeutic targets and clinical translation hurdles.

Main Results:

• Several key anti-inflammatory and pro-resolution pathways are implicated in atherosclerosis.
• Evidence suggests that targeting inflammation can significantly impact clinical manifestations.
• Significant challenges exist in developing and implementing these therapies effectively.

Conclusions:

• Targeting inflammation represents a promising strategy to combat atherosclerosis.
• Further research and development are needed to overcome barriers to clinical application.
• Successful translation could revolutionize the management of atherosclerotic heart disease.